IGF1 and acromegaly: Later, a meta-analysis including 160 patients with acromegaly treated with cabergoline as monotherapy reported that 34% of them achieved normal IGF-1 levels (mean cabergoline dose was 2.6 mg/week), and hormonal remission was predicted by lower IGF-1 levels and high PRL levels at baseline (45).